Biovail’s Cardizem LA Marketing Under State Scrutiny
This article was originally published in The Pink Sheet Daily
Executive Summary
The Massachusetts Attorney General’s office is pursuing a grand jury investigation of Biovail’s program to get physicians to prescribe its long-acting antihypertensive Cardizem LA.
You may also be interested in...
Biovail Agrees To Cardizem LA Guilty Plea
Federal charges say 2003 program gave docs $1,000 to write scrips.
Biovail Agrees To Cardizem LA Guilty Plea
Federal charges say 2003 program gave docs $1,000 to write scrips.
Biovail Settles For $10 Million On SEC Fraud Charges
Four executives still accused of overstating earnings to deceive investors.